Access the full text.
Sign up today, get DeepDyve free for 14 days.
NEIJT (1988)
Characterisation of 5-HT3 recognition sites in membranes of NG108-15 neuroblastoma-glioma cells with [3H]ICS 205-930Naunyn-Schmiedebergs Arch. Pharmacol, 337
J. Barnes, N. Barnes, S. Cooper (1992)
Behavioural pharmacology of 5-HT3 receptor ligandsNeuroscience & Biobehavioral Reviews, 16
David Nelson, David Thomas (1989)
[3H]-BRL 43694 (Granisetron), a specific ligand for 5-HT3 binding sites in rat brain cortical membranes.Biochemical pharmacology, 38 10
D. Hoyer, H. Neijt (1988)
Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.Molecular pharmacology, 33 3
I. Wijngaarden, M. Tulp, W. Soudijn (1990)
The concept of selectivity in 5-HT receptor research.European journal of pharmacology, 188 6
J. Barnes, Nicholas Barnes, B. Costall, James Ironside, R. Naylor (1989)
Identification and Characterisation of 5‐Hydroxytryptamine3 Recognition Sites in Human Brain TissueJournal of Neurochemistry, 53
(1988)
Recent advances in the neuropharmacology of 5 - HT 3 agonists and antagonists
S. Ireland, M. Tyers (1987)
Pharmacological characterization of 5‐hydroxytryptamine‐induced depolarization of the rat isolated vagus nerveBritish Journal of Pharmacology, 90
David Robertson, W. Bloomquist, Marlene Cohen, Leroy Reid, K. Schenck, David Wong (1990)
Synthesis and biochemical evaluation of tritium-labeled 1-methyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxa mide, a useful radioligand for 5HT3 receptors.Journal of medicinal chemistry, 33 12
S. Peroutka, A. Hamik (1988)
[3H]quipazine labels 5-HT3 recognition sites in rat cortical membranes.European journal of pharmacology, 148 2
M. Hamon, M. Gallissot, F. Ménard, H. Gozlan, S. Bourgoin, D. Vergé (1989)
5-HT3 receptor binding sites are on capsaicin-sensitive fibres in the rat spinal cord.European journal of pharmacology, 164 2
C. Milburn, S. Peroutka (1989)
Characterization of [3H]Quipazine Binding to 5‐Hydroxytryptamine3 Receptors in Rat Brain MembranesJournal of Neurochemistry, 52
J. Peters, J. Lambert (1989)
Electrophysiology of 5-HT3 receptors in neuronal cell lines.Trends in pharmacological sciences, 10 5
K. Watling, S. Aspley, C. Swain, J. Saunders (1988)
[3H]quaternised ICS 205-930 labels 5-HT3 receptor binding sites in rat brain.European journal of pharmacology, 149 3
L. Pinkus, N. Sarbin, D. Barefoot, J. Gordon (1989)
Association of [3H]zacopride with 5-HT3 binding sites.European journal of pharmacology, 168 3
N. Barnes, B. Costall, R. Naylor (1988)
[3H]Zacopride: Ligand for the Identification of 5‐HT3 Recognition SitesJournal of Pharmacy and Pharmacology, 40
J. Barnes, N. Barnes, S. Champaneria, B. Costall, R. Naylor (1990)
Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the ratNeuropharmacology, 29
J. Taylor, A. Wykes, Y. Gladish, W. Martin (1960)
New Inhibitor of Monoamine OxidaseNature, 187
(1990)
The effect of Ca 2 + and Mg 2 + ions on the binding of [ 3 H ] - Q ICS 205 - 930 to the 5 - HT 3 recognition site in rat brain whole cortex
F. Bolaños, L. Schechter, M. Miquel, M. Emerit, J. Rumigny, M. Hamon, Henri Gozlan (1990)
Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells.Biochemical pharmacology, 40 7
G. Pratt, N. Bowery, Gavin Kilpatrick, R. Leslie, N. Barnes, R. Naylor, B. Jones, D. Nelson, J. Palacids, P. Slater (1990)
Consensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrain.Trends in Pharmacological Sciences, 11
M. Bradford (1976)
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Analytical biochemistry, 72
D. Wong, D. Robertson, L. Reid (1989)
Specific [3H]LY278584 binding to 5-HT3 recognition sites in rat cerebral cortex.European journal of pharmacology, 166 1
Gavin Kilpatrick, N. Barnes, C. Cheng, B. Costall, M. Tyers (1991)
The pharmacological characterization of 5-HT3 receptor binding sites in rabbit ileum: Comparison with those in rat ileum and rat brainNeurochemistry International, 19
C. Waeber, K. Dixon, D. Hoyer, J. Palacios (1988)
Localisation by autoradiography of neuronal 5-HT3 receptors in the mouse CNS.European journal of pharmacology, 151 2
N. Sharif, E. Wong, D. Loury, Eric Stefanich, Anton Michel, R. Eglen, R. Whiting (1991)
Characteristics of 5‐HT3 binding sites in NG108‐15, NCB‐20 neuroblastoma cells and rat cerebral cortex using [3H]‐quipazine and [3H]‐GR65630 bindingBritish Journal of Pharmacology, 102
Gavin Kilpatrick, B. Jones, M. Tyers (1987)
Identification and distribution of 5-HT3 receptors in rat brain using radioligand bindingNature, 330
KILPATRICK (1990)
[3H]-GR67330, a very high affinity ligand for 5-HT3 receptorsNaunyn-Schmiedebergs Arch. Pharmacol, 342
P. Munson, D. Rodbard (1980)
Ligand: a versatile computerized approach for characterization of ligand-binding systems.Analytical biochemistry, 107 1
1 The pharmacological properties of 5‐HT3 receptor recognition sites labelled with (3H)‐(S)‐zacopride, (3H)‐LY278,584, (3H)‐granisetron and (3H)‐GR67330 in membranes prepared from the rat entorhinal cortex were investigated to assess the presence of cooperativity within the 5‐HT3 receptor complex. 2 In rat entorhinal cortex homogenates, (3H)‐(S)‐zacopride, (3H)‐LY278,584, (3H)‐granisetron and (3H)‐GR67330 labelled homogeneous densities of recognition sites (defined by granisetron, 10 μm) with high affinity (Bmax = 75 ± 5, 53 ± 5, 92 ± 6 and 79 ± 6 fmol mg−1 protein, respectively; pKd = 9.41 ± 0.04, 8.69 ± 0.14, 8.81 ± 0.06 and 10.14 ± 0.04 for (3H)‐(S)‐zacopride, (3H)‐LY278,584, (3H)‐granisetron and (3H)‐GR67330, respectively, n = 3–8). 3 Quipazine and granisetron competed for the binding of each of the radioligands in the rat entorhinal cortex preparation at low nanomolar concentrations (pIC50; quipazine 9.38–8.51, granisetron 8.62–8.03), whilst the agonists, 5‐hydroxytryptamine (5‐HT), phenylbiguanide (PBG) and 2‐methyl‐5‐HT competed at sub‐micromolar concentrations (pIC50; 5‐HT 7.16–6.42, PBG 7.52–6.40, 2‐methyl‐5‐HT 7.38–6.09). 4 Competition curves generated with increasing concentrations of quipazine, PBG, 5‐HT and 2‐methyl‐5‐HT displayed Hill coefficients greater than unity when the 5‐HT3 receptor recognition sites in the entorhinal cortex preparation were labelled with (3H)‐LY278,584, (3H)‐granisetron and (3H)‐GR67330. These competing compounds displayed Hill coefficients of around unity when the sites were labelled with (3H)‐(S)‐zacopride. Competition for the binding of (3H)‐(S)‐zacopride, (3H)‐LY278,584, (3H)‐granisetron and (3H)‐GR67330 by granisetron generated Hill coefficients around unity. 5 The nature of the interaction of competing compounds (quipazine, granisetron, PBG, 5‐HT, 2‐methyl‐5‐HT) for the (3H)‐(S)‐zacopride binding site in the rat entorhinal cortex preparation was not altered by the removal of the Krebs ions or the addition of the monoamine oxidase inhibitor, pargyline, to the HEPES/Krebs buffer. 6 In conclusion, the present studies provide further evidence towards the presence of cooperativity within the 5‐HT3 receptor macromolecule and indicate that either (3H)‐(S)‐zacopride labels a different site on the receptor complex from (3H)‐LY278,584, (3H)‐granisetron or (3H)‐GR67330, or it binds in such a manner as to prevent the conformatory change in the receptor protein responsible for the cooperative binding of agonists (and quipazine).
British Journal of Pharmacology – Wiley
Published: Feb 1, 1992
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.